The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.
Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...
Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...
The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback